临床试验外治疗的60名梅奥诊所骨髓纤维化患者对帕昔替尼治疗的反应和生存的预测因素

IF 8.2 1区医学 Q1 HEMATOLOGY

Haematologica Pub Date : 2025-03-20 DOI:10.3324/haematol.2025.287576

Maymona Abdelmagid, Jeanne M Palmer, Aref Al-Kali, Mehrdad Hefazi, James Foran, Kebede H Begna, Cecilia Y Arana Yi, Animesh Pardanani, Naseema Gangat, Ayalew Tefferi

引用次数: 0

摘要

不可用。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Predictors of response to pacritinib therapy and survival among 60 Mayo Clinic patients with myelofibrosis treated outside of clinical trials.

Not available.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Haematologica 医学-血液学

CiteScore

14.10

自引率

2.00%

发文量

349

审稿时长

3-6 weeks

期刊介绍： Haematologica is a journal that publishes articles within the broad field of hematology. It reports on novel findings in basic, clinical, and translational research. Scope: The scope of the journal includes reporting novel research results that: Have a significant impact on understanding normal hematology or the development of hematological diseases. Are likely to bring important changes to the diagnosis or treatment of hematological diseases.